No actionable signal from this filing, the conference call audio may contain strategic commentary, but the 6-K itself carries no immediate trading implications. Monitor for any subsequent material disclosures from Dr. Reddy's.
RDY drugs
RDY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 10 $13.19entry
- T+1 · 4mo ago −2.05%α −1.28% · $12.92
- T+5 · 4mo ago −3.71%α −3.15% · $12.70
- T+20 · 3mo ago −7.35%α −9.78% · $12.22
- T+60 · 6w ago −6.60%α −9.23% · $12.32
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Dr. Reddy's filed a Form 6-K furnishing Exhibit 99.1, an intimation letter to stock exchanges providing a weblink to the audio recording of a July 9, 2026 conference call. This is a routine regulatory filing with no new material financial or business disclosures.
Key Facts
- Furnished audio recording link from July 9, 2026 conference call.
- Filed as a 6-K with no financial data, guidance, or material event.
- Routine disclosure under India's SEBI Listing Regulations.
Financial Impact
No financial impact disclosed or estimable from filing content.
Risk Factors
- No material risks disclosed in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (RDY), Batch item 1 | 0001575872-26-000491 |
| Document: 0001575872-26-000491-index.html | 0001575872-26-000491 |
| Document: 0001575872-26-000491.txt | 0001575872-26-000491 |
| 6-K Filing (RDY), Batch item 4 | 0001575872-26-000491 |
| Document: 0001575872-26-000491-index.html | 0001575872-26-000491 |
| Document: 0001575872-26-000491.txt | 0001575872-26-000491 |
Track record
73 reports on RDY
7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.
Filters
- Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
- Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
- Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
- Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
- Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
- Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers